Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same

SPARC-derived tumor rejection antigenic peptides and medicaments comprising the same

US Patent 9120842 · Granted Sep 1, 2015

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Reflective mask blank for EUV lithography2021
CDCA1 epitope peptides for Th1 cells and vaccines containing the same2019
KIF20A epitope peptides for TH1 cells and vaccines containing the same2019
IMP-3 epitope peptides for TH1 cells and vaccines containing the same2017
Reflective mask blank for EUV lithography, and process for its inspection and pr2017
CDCA1 epitope peptides for Th1 cells and vaccines containing the same2017
LY6K epitope peptides for TH1 cells and vaccines containing the same2017
KIF20A epitope peptides for TH1 cells and vaccines containing the same2017
FOXM1 peptide and medicinal agent comprising the same2016
Cancer antigen and use thereof2016
Reflective mask blank for EUV lithography, method of manufacturing thereof, refl2016
Genes and polypeptides relating to breast cancers2015